Korean J Obstet Gynecol.  2010 Sep;53(9):833-837. 10.5468/kjog.2010.53.9.833.

Transient newborn neutropenia immediately after chemotherapy during pregnancy: A case report

• Kim EN
• Han KH
• Kim SA
• Jun JK

• KMID: 2078001
• DOI: http://doi.org/10.5468/kjog.2010.53.9.833

Abstract

The incidence of acute leukemia in pregnancy is as low as 1 in 75,000 pregnancies. There is no established guideline for the treatment of leukemia during midtrimester pregnancy. But nowadays, consensus is not to delay the leukemia treatment with chemotherapy even in pregnancy. Many authors reported successful outcomes of mothers and newborns. Because of the leukemia itself and side effects of the chemotherapy, anemia, thrombocytopenia and neutropenia are commonly encountered in women treated with chemotherapy. With chemotherapy in utero just before the delivery, the newborn could be neutopenic. We report one case of midtrimester pregnant woman who took chemotherapy for leukemia and suffered from neutropenic fever and preterm labor. The newborn was neutropenic. However, both the mother and the baby were successfully recovered from neutropenia.

Keyword

Pregnancy; Acute leukemia; Chemotherapy; Newborn; Neutropenia

MeSH Terms

Anemia
Consensus
Female
Fever
Humans
Incidence
Infant, Newborn
Leukemia
Mothers
Neutropenia
Obstetric Labor, Premature
Pregnancy
Pregnancy Trimester, Second
Pregnant Women
Thrombocytopenia

Figure

• 

  Figure 1 Newborn absolute neutrophil count (ANC): newborn neutropenia after chemotherapy in utero was recovered with granulocyte colony stimulating factor.

Reference

1. Pejovic T, Schwartz PE. Leukemias. Clin Obstet Gynecol. 2002. 45:866–878.

2. Caligiuri MA, Mayer RJ. Pregnancy and leukemia. Semin Oncol. 1989. 16:388–396.

3. Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol. 2004. 5:283–291.

4. Buekers TE, Lallas TA. Chemotherapy in pregnancy. Obstet Gynecol Clin North Am. 1998. 25:323–329.

5. Ali R, Ozkalemkas F, Ozcelik T, Ozkocaman V, Ozan U, Kimya Y, et al. Maternal and fetal outcomes in pregnancy complicated with acute leukemia: a single institutional experience with 10 pregnancies at 16 years. Leuk Res. 2003. 27:381–385.

6. Peleg D, Ben-Ami M. Lymphoma and leukemia complicating pregnancy. Obstet Gynecol Clin North Am. 1998. 25:365–383.

7. Aviles A, Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma. 2001. 2:173–177.

8. Doll DC, Ringenberg QS, Yarbro JW. Management of cancer during pregnancy. Arch Intern Med. 1988. 148:2058–2064.

9. Feliu J, Juarez S, Ordonez A, Garcia-Paredes ML, Gonzalez-Baron M, Montero JM. Acute leukemia and pregnancy. Cancer. 1988. 61:580–584.

10. Reynoso EE, Shepherd FA, Messner HA, Farquharson HA, Garvey MB, Baker MA. Acute leukemia during pregnancy: the Toronto Leukemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents. J Clin Oncol. 1987. 5:1098–1106.

11. Schafer AI. Teratogenic effects of antileukemic chemotherapy. Arch Intern Med. 1981. 141:514–515.

12. Juarez S, Cuadrado Pastor JM, Feliu J, Gonzalez Baron M, Ordonez A, Montero JM. Association of leukemia and pregnancy: clinical and obstetric aspects. Am J Clin Oncol. 1988. 11:159–165.